AMBROSETTI, Achille
AMBROSETTI, Achille
DIPARTIMENTO DI MEDICINA
BCR-ABL fusion transcript b2a2 is associated with a higher risk of non-optimal early response in CP-CML patients treated with standard dose imatinib: a study from Gruppo Triveneto LMC.
2016-01-01 G., Binotto; M., Tiribelli; Bonifacio, Massimiliano; L., Frison; M., Narbergoj; F., De Marchi; Scaffidi, Luigi; M., Medeot; E., Maino; E., Calistri; A., Bonalumi; Krampera, Mauro; Ambrosetti, Achille; R., Fanin; G., Semenzato
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia and may provide prognostic informations
2016-01-01 Montemezzi, Rachele; Parisi, Alice; DE MATTEIS, Giovanna; Lippi, Giuseppe; Chilosi, Marco; Krampera, Mauro; Ambrosetti, Achille; Bonifacio, Massimiliano
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations
2016-01-01 Bonifacio, Massimiliano; Montemezzi, Rachele; Parisi, Alice; DE MATTEIS, Giovanna; Scaffidi, Luigi; Lippi, Giuseppe; Chilosi, Marco; Pizzolo, Giovanni; Krampera, Mauro; Ambrosetti, Achille
Comparison of dasatinib and nilotinib as second-line therapy after imatinib failure in chronic phase chronic myeloid leukemia patients.
2015-01-01 Tiribelli, M; Bonifacio, Massimiliano; Binotto, G; Maino, E; Calistri, E; De Marchi, F; Scaffidi, Luigi; Frison, Luca; Medeot, M; Ambrosetti, Achille; Semenzato, G; Fanin, R.
CT IMAGING OF PRIMARY PANCREATIC LYMPHOMA
2017-01-01 Facchinelli, D; Boninsegna, E; Zamboni, Ga; Ambrosetti, Mc; Pozzi Mucelli, R; Parisi, A; Veneri, D; Ambrosetti, A
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis
2007-01-01 Scupoli, Maria; Perbellini, Omar; F., Cioffi; Lovato, Ornella; Zanotti, Roberta; Malpeli, Giorgio; Ambrosetti, Achille; Scarpa, Aldo; Pizzolo, Giovanni
EPSTEIN-BARR VIRUS DNA LOAD IN CHRONIC LYMPHOCYTIC LEUKEMIA IS AN INDEPENDENT PREDICTOR OF CLINICAL COURSE AND SURVIVAL
2015-01-01 Carli, G.; Visco, C.; Falisi, E.; Perbellini, O.; Pascarella, M.; Rossi, D.; Novella, E.; Giaretta, I.; Cavallini, C.; Scupoli, M. T.; De Rossi, A.; D'Amore, E. S.; Rassu, M.; Gaidano, G.; Pizzolo, G.; Ambrosetti, A.; Rodeghiero, F.
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche
1997-01-01 Ricetti, Maria Maddalena; Rigo, Antonella; Krampera, Mauro; C., Vincenzi; G. P., Nadali; Ambrosetti, Achille; Todeschini, Giuseppe; Pizzolo, Giovanni; G., Perona
High incidence of autoimmune complications in 82 patients with non-MALT marginal zone lymphomas.
2007-01-01 Rinaldi, M; Ambrosetti, Achille; Bonifacio, Massimiliano; Lestani, M; Perbellini, Omar; Zorzi, Mg; Bonani, A; Nichele, I; Quaresmini, G; Pizzolo, G.
Inhibition of Notch signalling overcomes bone marrow stromal-mediated anti-apoptotic and chemoresistance effects in AML.
2015-01-01 Takam Kamga, Paul; Bassi, Giulio; Cassaro, Adriana; Midolo, Martina; Di Trapani, Mariano; Canella, Francesca; Carusone, Roberta; Gatti, Alessandro; Resci, Federica; Perbellini, O; Gottardi, M; Bonifacio, Massimiliano; NWABO KAMDJE, Armel Herve'; Ambrosetti, Achille; Krampera, Mauro
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia
2016-01-01 Scupoli, Maria Teresa; Cavallini, Chiara; Putta, Santosh; Visco, Carlo; Purvis, Norman; Rossi, Davide; Mimiola, Elda; Perbellini, Omar; Lovato, Ornella; Falisi, Erika; Facco, Monica; Trentin, Livio; Gaidano, Gianluca; Semenzato, Gianpietro; Romanelli, Maria; Ambrosetti, Achille; Pizzolo, Giovanni; Cesano, Alessandra
Modified HyperCVAD and rituximab for the treatment of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
2013-01-01 Bonifacio, Massimiliano; Furlani, Lara; Zamo', Alberto; Corradi, Gabriele; Chilosi, Marco; Todeschini, Giuseppe; Pizzolo, G; Ambrosetti, Achille
Molecular “warning” CML patients: a retrospective study of Gruppo Triveneto LMC.
2015-01-01 Binotto, G; Tiribelli, M; Bonifacio, Massimiliano; Maino, E; Calistri, E; Gianesello, Ilaria; Bertorelle, R; Gherlinzoni, F; Ambrosetti, Achille; Fanin, R; Semenzato, G.
OFATUMUMAB AND LENALIDOMIDE PREFERENTIALLY INHIBIT B-CELL RECEPTOR SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS WITH MUTATED IGHV
2016-01-01 Cavallini, Chiara; Guardalben, Emanuele; Ambrosetti, Achille; Veneri, Dino; Pizzolo, Giovanni; Scupoli, Maria
PBX/E2A transcript positive B-lymphoblastic leukemia (B-ALL) presenting with bilateral renal and myocardial involvement: a case report.
2013-01-01 Carli, G; Guardalben, Emanuele; Bonifacio, Massimiliano; Meneghini, V; Tecchio, Cristina; Cucca, M; Pizzolo, G; Ambrosetti, Achille
Predictive factors of stable deep molecular response in chronic myeloid leukemia patients treated with imatinib standard dose: a study from the Gruppo Triveneto LMC.
2015-01-01 Bonifacio, Massimiliano; Scaffidi, Luigi; Binotto, G; De Marchi, F; Maino, E; Calistri, E; Bonalumi, Angela; Frison, Luca; Marin, L; Medeot, M; DE MATTEIS, Giovanna; Fanin, R; Semenzato, G; Ambrosetti, Achille; Tiribelli, M.
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure
2016-01-01 Bonifacio, Massimiliano; Binotto, G.; Tiribelli, M.; Scaffidi, Luigi; Iurlo, A.; Cibien, F.; Maino, E.; Guella, A.; Festini, G.; Minotto, C.; De Biasi, E.; Frison, Luca; De Marchi, F.; Medeot, M.; Bucelli, C.; Calistri, E.; Stulle, M.; Gherlinzoni, F.; Cortelezzi, A.; Fanin, R.; Semenzato, Giampietro; Krampera, Mauro; Pizzolo, Giovanni; Ambrosetti, Achille
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients
2007-01-01 Zanotti, Roberta; Ambrosetti, Achille; Scupoli, Maria; Riviera, P.; Randon, F.; Brutti, N.; Lovato, Ornella; Corgnati, A.; Perbellini, Omar; Lestani, Maurizio; Chilosi, Marco; Pizzolo, Giovanni
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS
2005-01-01 Zanotti, Roberta; Ambrosetti, Achille; Riviera, P; Scupoli, Maria; Remo, A; Brutti, N; Lestani, Maurizio; Rinaldi, M; Pizzolo, Giovanni
Real-life comparison of dasatinib and nilotinib as second-line therapy after imatinib failure for chronic phase CML
2016-01-01 M., Tiribelli; Bonifacio, Massimiliano; G., Binotto; A., Iurlo; F., Cibien; E., Maino; A., Guella; G., Festini; C., Minotto; E., De Biasi; F., De Marchi; Scaffidi, Luigi; L., Frison; C., Bucelli; M., Medeot; E., Calistri; R., Sancetta; M., Stulle; Krampera, Mauro; F., Gherlinzoni; G., Semenzato; Ambrosetti, Achille; R., Fanin
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| BCR-ABL fusion transcript b2a2 is associated with a higher risk of non-optimal early response in CP-CML patients treated with standard dose imatinib: a study from Gruppo Triveneto LMC. | 1-gen-2016 | G., Binotto; M., Tiribelli; Bonifacio, Massimiliano; L., Frison; M., Narbergoj; F., De Marchi; Scaffidi, Luigi; M., Medeot; E., Maino; E., Calistri; A., Bonalumi; Krampera, Mauro; Ambrosetti, Achille; R., Fanin; G., Semenzato | |
| CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia and may provide prognostic informations | 1-gen-2016 | Montemezzi, Rachele; Parisi, Alice; DE MATTEIS, Giovanna; Lippi, Giuseppe; Chilosi, Marco; Krampera, Mauro; Ambrosetti, Achille; Bonifacio, Massimiliano | |
| CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations | 1-gen-2016 | Bonifacio, Massimiliano; Montemezzi, Rachele; Parisi, Alice; DE MATTEIS, Giovanna; Scaffidi, Luigi; Lippi, Giuseppe; Chilosi, Marco; Pizzolo, Giovanni; Krampera, Mauro; Ambrosetti, Achille | |
| Comparison of dasatinib and nilotinib as second-line therapy after imatinib failure in chronic phase chronic myeloid leukemia patients. | 1-gen-2015 | Tiribelli, M; Bonifacio, Massimiliano; Binotto, G; Maino, E; Calistri, E; De Marchi, F; Scaffidi, Luigi; Frison, Luca; Medeot, M; Ambrosetti, Achille; Semenzato, G; Fanin, R. | |
| CT IMAGING OF PRIMARY PANCREATIC LYMPHOMA | 1-gen-2017 | Facchinelli, D; Boninsegna, E; Zamboni, Ga; Ambrosetti, Mc; Pozzi Mucelli, R; Parisi, A; Veneri, D; Ambrosetti, A | |
| CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis | 1-gen-2007 | Scupoli, Maria; Perbellini, Omar; F., Cioffi; Lovato, Ornella; Zanotti, Roberta; Malpeli, Giorgio; Ambrosetti, Achille; Scarpa, Aldo; Pizzolo, Giovanni | |
| EPSTEIN-BARR VIRUS DNA LOAD IN CHRONIC LYMPHOCYTIC LEUKEMIA IS AN INDEPENDENT PREDICTOR OF CLINICAL COURSE AND SURVIVAL | 1-gen-2015 | Carli, G.; Visco, C.; Falisi, E.; Perbellini, O.; Pascarella, M.; Rossi, D.; Novella, E.; Giaretta, I.; Cavallini, C.; Scupoli, M. T.; De Rossi, A.; D'Amore, E. S.; Rassu, M.; Gaidano, G.; Pizzolo, G.; Ambrosetti, A.; Rodeghiero, F. | |
| Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche | 1-gen-1997 | Ricetti, Maria Maddalena; Rigo, Antonella; Krampera, Mauro; C., Vincenzi; G. P., Nadali; Ambrosetti, Achille; Todeschini, Giuseppe; Pizzolo, Giovanni; G., Perona | |
| High incidence of autoimmune complications in 82 patients with non-MALT marginal zone lymphomas. | 1-gen-2007 | Rinaldi, M; Ambrosetti, Achille; Bonifacio, Massimiliano; Lestani, M; Perbellini, Omar; Zorzi, Mg; Bonani, A; Nichele, I; Quaresmini, G; Pizzolo, G. | |
| Inhibition of Notch signalling overcomes bone marrow stromal-mediated anti-apoptotic and chemoresistance effects in AML. | 1-gen-2015 | Takam Kamga, Paul; Bassi, Giulio; Cassaro, Adriana; Midolo, Martina; Di Trapani, Mariano; Canella, Francesca; Carusone, Roberta; Gatti, Alessandro; Resci, Federica; Perbellini, O; Gottardi, M; Bonifacio, Massimiliano; NWABO KAMDJE, Armel Herve'; Ambrosetti, Achille; Krampera, Mauro | |
| Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia | 1-gen-2016 | Scupoli, Maria Teresa; Cavallini, Chiara; Putta, Santosh; Visco, Carlo; Purvis, Norman; Rossi, Davide; Mimiola, Elda; Perbellini, Omar; Lovato, Ornella; Falisi, Erika; Facco, Monica; Trentin, Livio; Gaidano, Gianluca; Semenzato, Gianpietro; Romanelli, Maria; Ambrosetti, Achille; Pizzolo, Giovanni; Cesano, Alessandra | |
| Modified HyperCVAD and rituximab for the treatment of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. | 1-gen-2013 | Bonifacio, Massimiliano; Furlani, Lara; Zamo', Alberto; Corradi, Gabriele; Chilosi, Marco; Todeschini, Giuseppe; Pizzolo, G; Ambrosetti, Achille | |
| Molecular “warning” CML patients: a retrospective study of Gruppo Triveneto LMC. | 1-gen-2015 | Binotto, G; Tiribelli, M; Bonifacio, Massimiliano; Maino, E; Calistri, E; Gianesello, Ilaria; Bertorelle, R; Gherlinzoni, F; Ambrosetti, Achille; Fanin, R; Semenzato, G. | |
| OFATUMUMAB AND LENALIDOMIDE PREFERENTIALLY INHIBIT B-CELL RECEPTOR SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS WITH MUTATED IGHV | 1-gen-2016 | Cavallini, Chiara; Guardalben, Emanuele; Ambrosetti, Achille; Veneri, Dino; Pizzolo, Giovanni; Scupoli, Maria | |
| PBX/E2A transcript positive B-lymphoblastic leukemia (B-ALL) presenting with bilateral renal and myocardial involvement: a case report. | 1-gen-2013 | Carli, G; Guardalben, Emanuele; Bonifacio, Massimiliano; Meneghini, V; Tecchio, Cristina; Cucca, M; Pizzolo, G; Ambrosetti, Achille | |
| Predictive factors of stable deep molecular response in chronic myeloid leukemia patients treated with imatinib standard dose: a study from the Gruppo Triveneto LMC. | 1-gen-2015 | Bonifacio, Massimiliano; Scaffidi, Luigi; Binotto, G; De Marchi, F; Maino, E; Calistri, E; Bonalumi, Angela; Frison, Luca; Marin, L; Medeot, M; DE MATTEIS, Giovanna; Fanin, R; Semenzato, G; Ambrosetti, Achille; Tiribelli, M. | |
| Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure | 1-gen-2016 | Bonifacio, Massimiliano; Binotto, G.; Tiribelli, M.; Scaffidi, Luigi; Iurlo, A.; Cibien, F.; Maino, E.; Guella, A.; Festini, G.; Minotto, C.; De Biasi, E.; Frison, Luca; De Marchi, F.; Medeot, M.; Bucelli, C.; Calistri, E.; Stulle, M.; Gherlinzoni, F.; Cortelezzi, A.; Fanin, R.; Semenzato, Giampietro; Krampera, Mauro; Pizzolo, Giovanni; Ambrosetti, Achille | |
| Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients | 1-gen-2007 | Zanotti, Roberta; Ambrosetti, Achille; Scupoli, Maria; Riviera, P.; Randon, F.; Brutti, N.; Lovato, Ornella; Corgnati, A.; Perbellini, Omar; Lestani, Maurizio; Chilosi, Marco; Pizzolo, Giovanni | |
| PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS | 1-gen-2005 | Zanotti, Roberta; Ambrosetti, Achille; Riviera, P; Scupoli, Maria; Remo, A; Brutti, N; Lestani, Maurizio; Rinaldi, M; Pizzolo, Giovanni | |
| Real-life comparison of dasatinib and nilotinib as second-line therapy after imatinib failure for chronic phase CML | 1-gen-2016 | M., Tiribelli; Bonifacio, Massimiliano; G., Binotto; A., Iurlo; F., Cibien; E., Maino; A., Guella; G., Festini; C., Minotto; E., De Biasi; F., De Marchi; Scaffidi, Luigi; L., Frison; C., Bucelli; M., Medeot; E., Calistri; R., Sancetta; M., Stulle; Krampera, Mauro; F., Gherlinzoni; G., Semenzato; Ambrosetti, Achille; R., Fanin |